Pharma leaders will post $55 billion in 2020

Pl top 100 pharma companies with key findings released in December issue of Pharmaleaders Magazine.
By: pharmaleaders
 
Dec. 18, 2010 - PRLog -- New Delhi : The Indian pharmaceuticals market looks poised to grow to $55 billion in 2020, sources & findings in latest issue of Pharmaleaders Magazine revealed. Cancer is one of the most expensive diseases to treat, with projected costs during 2010 expected to approach $264 billion also featured in the report. On average, an oncologist spends $2.3 million annually on such products. TOP 15 Therapeutic areas of 2010 : Oncology is leading category in size and growth potential in 2010. If M&A activity is a harbinger of economic outlook and business confidence, then Indian corporate have had a great 2010 so far. Not only did the year see merger and acquisition (M&A) deal values shoot past the 2007 high, it also saw the return of mega deals and risk appetite among corporate, reveals the data put out by Pharmaleaders, As the calendar year draws to a close, here's a look at what drove the M&A moves of Corporate India in 2010. While in 2009 companies were keen to buy domestic assets, driven by the financial crisis that diverted attention homewards, 2010 saw some of that sheen wear off. Not only were there fewer deals, the total deal value, at $12.4 billion, recorded only a 3.2 per cent growth over the $11.9 billion announced value in 2009. From $16.5 million in 2009, when there were 1,235 deals for an aggregate deal value of $20.3 billion, the average deal value has increased to $51.4 million in 2010 (1,047 deals for an announced value of about $53.8 billion).
Pharmaleaders, an International bi-monthly Magazine known for its unbiased & independent bare-to-all reporting also has carried out interviews with the leading luminaries of the healthcare & Lifescience Industry. Prominent Industry Captains like Dr Rashmi Barbhaiya, CEO and Managing Director of India’s most watched firm, Advinus Therapeutics Ltd as he revealed how ADVINUS will unquestionably be recognised as India's first true innovation-driven pharma company in 2020. Other Leading Figures included Narayan Gad of Panacea Biotech, Pulin Shroff of Charak Pharma & some of the leading figures in the global Pharmaceutical Industry. Dr B.P.S. Reddy of Hetero Drug’s ambition of reaching a Billion $ Company soon also featured in the December Issue of Pharmaleaders Magazine. Pharmaleaders also featured an in-depth feature on debt-ridden Wockhard’s growth strategy in the new decade. Pharmaleaders featured how Wockhardt’s Founder Chairman was trapped in various financial hassles resulting in lending & not paying in time but most importantly Pharmaleaders (www.pharmaleaders.co.in ) projected that Khorakiwala will remain not out in Second Innings as it described “ Habil Khorakiwala of Wockhardt will set precedence to others on how to cope under pressure & hit a ton, Pharmaleaders quoted in its feature. It is important to note that following a series of setbacks, trade pundits had written off Wockhardt as a ‘spent force’ but proved everybody wrong & bounced back with some strong financials only to indicate that Habil Khorakiwala will pose as a big force in days to come. Pharmaleaders Magazine is a voice of Global Healthcare Industry. It believes in bringing ground-breaking stories & expose the hidden truths that has rocked so far.

# # #

Pharmaleaders is a voice of Global Healthcare Industry. It believes in bringing ground-breaking stories & expose the hidden truths that has rocked so far. It is a leading bi-monthly that focusses pharmaleaders who are different & have a different perspectives
End
Source:pharmaleaders
Email:***@pharmaleaders.co.in Email Verified
Zip:56400054
Tags:Pharmaleaders, Pharma Research, December Issue, Pharma Marketring, Panacea, Leaders
Industry:Media, Health, Research
Location:Mumbai - Maharashtra - India
Account Email Address Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share